APOE and Cognitive impairment: Sensitivity analyses showed that these minimally impacted the significant findings (see S22–S26 Tables for analyses incorporating batch effects, restricting to rare variants (MAF≤0.01), and stratifying by APOE ε4 and cognitive impairment), although the magnitude of the single-variant effects tended to be larger among those who became cognitively impaired.